Inify Laboratories AB - AGM Information 2022

Notice to Extraordinary General Meeting in Inify Laboratories AB (publ)

STOCKHOLM - July 28, 2022 - Inify Laboratories AB (publ) hereby invites its

shareholders to en Extraordinary General Meeting on August 30th, 2022. Please

find attached the invitation including agenda and details on how to register and

vote. Please contact the companys CFO Ann-Charlotte Linderoth at e-mail: ann

[email protected] for any questions regarding the EGM.

Inify Laboratories provides cancer diagnostics through ultra-modern laboratory

services within histopathology. Fully digital, standardized and AI- supported

workflow is applied to optimize quality and response times, initially for

prostate cancer. The concept is scalable and extendible to other diagnosis. The

company origins from ContextVision and became independent in February 2022. The

company is based in Sweden and listed on Euronext Growth Oslo under the ticker

INIFY.

AI assistant